Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Spyre Therapeutics Inc., 3 years.
Spyre Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 19, 2024 | Rhythm Pharmaceuticals Inc. | Open-market sale | −15,515 | $39.22 | $608,498 |
| Feb 16, 2024 | Rhythm Pharmaceuticals Inc. | Grant or award | +33,750 | — | — |
| Feb 13, 2024 | Rhythm Pharmaceuticals Inc. | Open-market sale | −709 | $49.82 | $35,322 |
| Feb 12, 2024 | Rhythm Pharmaceuticals Inc. | Open-market sale | −1,209 | $51.38 | $62,118 |
| Feb 11, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +2,344 | — | — |
| Feb 9, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +4,063 | — | — |
| Feb 1, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +4,925 | — | — |
| Feb 1, 2024 | Rhythm Pharmaceuticals Inc. | Open-market sale | −1,616 | $45.06 | $72,817 |
| Dec 29, 2023 | Rhythm Pharmaceuticals Inc. | Option exercise | +10,500 | $6.88 | $72,240 |
| Dec 6, 2023 | Rhythm Pharmaceuticals Inc. | Option exercise | +20,000 | $6.88 | $137,600 |
| Dec 6, 2023 | Rhythm Pharmaceuticals Inc. | Open-market sale | −20,000 | $40.00 | $800,000 |
| Dec 5, 2023 | Rhythm Pharmaceuticals Inc. | Option exercise | +7,026 | $6.88 | $48,339 |
| Dec 5, 2023 | Rhythm Pharmaceuticals Inc. | Open-market sale | −7,026 | $35.06 | $246,332 |
| Nov 24, 2023 | Rhythm Pharmaceuticals Inc. | Option exercise | +10,974 | $6.88 | $75,501 |
| Nov 24, 2023 | Rhythm Pharmaceuticals Inc. | Open-market sale | −10,974 | $35.02 | $384,309 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.